Rosai-Dorfman-Destombes disease in adults: a single center experience
Annals of Hematology · 2024
DOI: 10.1007/s00277-024-06019-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Emily Leung und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of British Columbia, Vancouver, BC, Canada. Hauptthemen laut MEDLINE: Histiocytosis, Sinus, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Recent advances in Rosai-Dorfman-Destombes disease (RDD), notably molecular testing, targeted therapy, and PET-CT imaging, hold promise for better recognition and improved outcomes. This study presents patients diagnosed and treated in a "real world" setting, where navigating limited resources must be considered. This retrospective single-center review includes 15 adult patients diagnosed with RDD at Vancouver General Hospital between November 2015 and October 2023. The cohort comprised five males and ten females with a median age 53 years (range 19-80 years). All 15 patients had extra-nodal disease; 11 patients exclusively had extra-nodal disease, and four patients also had lymph node involvement. Seven patients had tissue next-generation sequencing, identifying MAP2K1 mutations in four cases and a KRAS p.K117N mutation in one case that was treated with targeted therapy using trametinib. PET-CT was used for disease staging in four cases. Six patients with refractory disease tolerated lenalidomide and dexamethasone without significant toxicity; three patients achieved complete response, and three had partial response. This study highlights RDD's diverse extra-nodal manifestations. Lenalidomide combined with dexamethasone is an effective and well-tolerated treatment option for select patients, especially those with refractory disease. Broad utilization of NGS and PET-CT can positively influence management decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
- Department of Radiology, University of British Columbia, Vancouver, BC, Canada.
- Department of Neurology, University of British Columbia, Vancouver, BC, Canada.
- Division of Medical Oncology, BC Cancer Agency, Vancouver, BC, Canada.
- Division of Hematology, University of British Columbia, Vancouver, BC, Canada.
Förderung
- NCI NIH HHS
Zitieren
APA
Leung, E., Pryma, C., Murphy, S., Harrison, R., Peterson, E., Tsang, P. W. K., Varghese, J., You, X. J., Slack, G. W., Skinnider, B. F., Ng, T., Young, S., Burrell, S., Stubbins, R., Lim, H., Carruthers, M., Dutz, J., Diamond, E. L., & Chen, L. Y. C. (2024). Rosai-Dorfman-Destombes disease in adults: a single center experience. Annals of Hematology. https://doi.org/10.1007/s00277-024-06019-w
Vancouver
Leung E, Pryma C, Murphy S, Harrison R, Peterson E, Tsang PWK, et al. Rosai-Dorfman-Destombes disease in adults: a single center experience. Annals of Hematology. 2024. doi:10.1007/s00277-024-06019-w
BibTeX
@article{Leung2024,
author = {Leung, Emily and Pryma, Collin and Murphy, Stephen and Harrison, Rebecca and Peterson, Erica and Tsang, Peter W K and Varghese, Julia and You, Xiaotian Julie and Slack, Graham W and Skinnider, Brian F and Ng, Tony and Young, Sean and Burrell, Steven and Stubbins, Ryan and Lim, Howard and Carruthers, Mollie and Dutz, Jan and Diamond, Eli L and Chen, Luke Y C},
title = {Rosai-Dorfman-Destombes disease in adults: a single center experience},
journal = {Annals of Hematology},
year = {2024},
doi = {10.1007/s00277-024-06019-w}
}
EUVIMED